GREENSBORO, N.C., Jan. 27 /PRNewswire/ -- NeuIsys Imaging System Solutions, LLC, a leader in providing state-of-the-art CT and MR imaging systems to physician practices, announced today that three gastroenterology (GI) practices have entered into agreements with NeuIsys to plan, install, and service the recently FDA approved NeuViz 16 Multi-Slice Computed Tomography (CT) System.
Joining the NeuIsys family of Urology, Internal Medicine, General Surgery, Neurology, Orthopedic, and Neurosurgery practices, these GI groups add an additional dimension of patient care to the NeuIsys universe. With last year's addition of virtual colonoscopy to the American Cancer Society's preferred method of screening for colon rectal cancer, the NeuViz 16 Multi-Slice CT is the ideal diagnostic tool to implement a program to broaden the detection of curable colon cancers. The GI groups, located in Georgia, Texas, and California, selected NeuIsys because of its breadth of experience, its turn key service, and its focus on private practices.
"We are very proud to announce these leaders in gastroenterology have teamed with NeuIsys to bring advanced imaging technologies to their patients. We expect that these clinicians will be much better prepared and equipped to directly diagnose Colorectal diseases, and provide more timely resolutions. This is directly in keeping with our mission to bring imaging closer to the patient," states NeuIsys CEO, Kim Russell.
NeuIsys Imaging Systems Solutions, LLC, headquartered in Greensboro, North Carolina, is a leader in providing state-of-the-art CT and MR imaging systems to physician practices, community hospitals, and imaging centers. NeuIsys is an exclusive North American distributor for Neusoft® Medical Systems and markets an array of products including the NeuViz Dual and NeuViz 16 multi-slice CT systems, the SuperStar HD open MRI system, multi-modality advanced visualization workstations, image management solutions, digital x-ray, and ultrasound products. For more information, please visit www.neuisys.com or call 877.299.9052.
Copyright©2010 PR Newswire.
All rights reserved